RecruitingNCT07508891
Characterisation of phenotYpes in aCute Heart faiLure patiEnts
Sponsor
Universitätsklinikum Hamburg-Eppendorf
Enrollment
1,000 participants
Start Date
Mar 1, 2019
Study Type
OBSERVATIONAL
Conditions
Summary
An observational cohort study to evaluate the benefit of functional parameters, radiomics and blood biomarkers to predict the outcome of patients with acute heart failure.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with acute heart failure, cardiogenic shock, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07508891
Related Trials
Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock
NCT072939238 locations
COMPARE-VENT Feasibility Pilot Study
NCT076562591 location
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
NCT06008197315 locations
Infusion of Furosemide to Improve Diuretic Efficiency in Acute Heart Failure
NCT075775961 location
Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO
NCT056990051 location